Replies to post #9662 on BioCorRx Inc. (BICX)

[Kizersosae]

Well hopefully there is a preclinical update... could be last chance to buy in single digits before good news today depending on teleconference.

To those who don't know, in May the FDA granted Biocorrx a PRE IND meeting. The one hiccup was that they were granted a September 19th meeting which was so far off from when we were back in May. CEO Granier stated at the time that they are going to continue to conduct pre clinicals on BICX101 to further the Naltrexone effects. Let's hope they update the pre clinical public data so we can start our PPS climb towards September 19th.